Clinical Study | Office of Clinical Research

A Phase 1 Study Of Stereotactic Body Radiotherapy (Sbrt) For The Treatment Of Multiple Metastases

Posted Date: May 15, 2019

Investigator: Kevin Redmond
Type of Study: Drug

This research is being done to study the safety of giving high doses of radiation to cancer that has spread to other parts of the body. This type of radiation is called stereotactic body radiotherapy [SBRT]). SBRT delivers high doses of radiation to an exact target.

Criteria:

To Be Eligible For This Study, Patients Must Have Breast, Lung Or Prostate Cancer That Has Spread To

Keywords:

Phase I, Cancer, Nrg-Br001, Radiation, Solid Tumor

For More Information:

Uc Cancer Center
513-584-7698
kastla@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List